SLC5A1 and breast carcinoma: In turn, lactic acid triggers the HIF-1α/STAT3 axis in M2-like TAMs leading to the release of EGF and subsequent activation of EGFR/PI3K/AKT in breast cancer cells to elevate the expression of SGLT1 and promotion of drug resistance (57).